MAP3K1
Top inhibitors
| Drug | Inhibition % | Gini |
|---|---|---|
| Lorlatinib | 68.2 | 0.69 |
| Pazopanib | 50.5 | 0.67 |
| Crizotinib | 45.8 | 0.58 |
| Bosutinib | 44.2 | 0.55 |
| Ponatinib | 42.3 | 0.53 |
| Ripretinib | 32.6 | 0.67 |
| Tivozanib | 29.3 | 0.67 |
| Dasatinib | 25.7 | 0.70 |
| Pexidartinib | 24.9 | 0.63 |
| Regorafenib | 19.6 | 0.72 |
| Sorafenib | 17.3 | 0.78 |
| Ibrutinib | 17.3 | 0.72 |
| Baricitinib | 17.1 | 0.62 |
| Ceritinib | 14.6 | 0.62 |
| Cabozantinib | 14.0 | 0.75 |
Known variants
No variants catalogued.